Masatoshi Kurihara1, Hideyuki Kataoka, Aki Ishikawa, Reina Endo. 1. Pneumothorax Research Center and Thoracic Surgery Division, Nissan Tamagawa Hospital, 4-8-1 Seta, Setagaya-ku, Tokyo, 156-0095, Japan. kuri@tf6.so-net.ne.jp
Abstract
OBJECTIVE: Currently, the treatment of pneumothorax varies among hospitals. Three factors account for the differences. First, pneumothorax expresses the state of disease instead of the disease itself. Some pneumothoraces heal on their own but patients with pneumothorax due to chronic diseases may need further intervention. The decision for the choice of treatment is up to the physician. Second, it is insufficient to treat pneumothorax with current treatment guidelines. Third, prognosis and follow-up after pneumothorax treatment is not well documented. Therefore, verification/assessment of treatment and its effect is insufficient. METHODS: To prevent postoperative bulla neogenesis, the "covering technique" is most effective. Chemical pleurodesis has shown a great number of recurrences and has led to inconveniences, such as various results among individuals. Therefore, it should not be the recommended therapy. RESULTS AND CONCLUSION: Intractable pneumothorax in elderly patients has been increasing year after year. Interventional treatments such as endobronchial Watanabe spigot embolization and the thoracographic fibrin glue sealing method are expected to become more common in the future, keeping some patients from undergoing surgery. Causes are still unknown for certain pneumothoraces in women, and there are still numerous cases of postoperative recurrence among young males. Further studies in this field are expected in future.
OBJECTIVE: Currently, the treatment of pneumothorax varies among hospitals. Three factors account for the differences. First, pneumothorax expresses the state of disease instead of the disease itself. Some pneumothoraces heal on their own but patients with pneumothorax due to chronic diseases may need further intervention. The decision for the choice of treatment is up to the physician. Second, it is insufficient to treat pneumothorax with current treatment guidelines. Third, prognosis and follow-up after pneumothorax treatment is not well documented. Therefore, verification/assessment of treatment and its effect is insufficient. METHODS: To prevent postoperative bulla neogenesis, the "covering technique" is most effective. Chemical pleurodesis has shown a great number of recurrences and has led to inconveniences, such as various results among individuals. Therefore, it should not be the recommended therapy. RESULTS AND CONCLUSION: Intractable pneumothorax in elderly patients has been increasing year after year. Interventional treatments such as endobronchial Watanabe spigot embolization and the thoracographic fibrin glue sealing method are expected to become more common in the future, keeping some patients from undergoing surgery. Causes are still unknown for certain pneumothoraces in women, and there are still numerous cases of postoperative recurrence among young males. Further studies in this field are expected in future.
Authors: Khalid F Almoosa; Jay H Ryu; Jose Mendez; J Terrill Huggins; Lisa R Young; Eugene J Sullivan; Janet Maurer; Francis X McCormack; Steven A Sahn Journal: Chest Date: 2006-05 Impact factor: 9.410
Authors: Jay H Ryu; Joel Moss; Gerald J Beck; Jar-Chi Lee; Kevin K Brown; Jeffrey T Chapman; Geraldine A Finlay; Eric J Olson; Stephen J Ruoss; Janet R Maurer; Thomas A Raffin; Hannah H Peavy; Kevin McCarthy; Angelo Taveira-Dasilva; Francis X McCormack; Nilo A Avila; Rosamma M Decastro; Susan S Jacobs; Mario Stylianou; Barry L Fanburg Journal: Am J Respir Crit Care Med Date: 2005-10-06 Impact factor: 21.405
Authors: K S Naunheim; M J Mack; S R Hazelrigg; M K Ferguson; P F Ferson; T M Boley; R J Landreneau Journal: J Thorac Cardiovasc Surg Date: 1995-06 Impact factor: 5.209
Authors: Arife Zeybek; Serdar Kalemci; Ozlem Gürünlü Alma; Alev Süzen; Murat Akgül; Kadir Koç Journal: Iran Red Crescent Med J Date: 2013-02-05 Impact factor: 0.611